Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Michael Koenigsmann | Researchclopedia

Back to researchers

Michael Koenigsmann

Onkozentrum Dresden

107

Works

6,132

Citations

28

h-index

49

i10-index

Research Topics

Acute Myeloid Leukemia Research Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research

Affiliations

Goethe University Frankfurt2006–2006

Leibniz University Hannover2019–2020

Harvard University1990–1992

Universität Hamburg2004–2004

University of Freiburg2006–2006

Top Works

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

Salah‐Eddin Al‐Batran,Nils Homann,et al.

20192,487 citations

Neutropenia and Cancer Infections

Hematopoietic Stem Cell Transplantation

Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial

Salah‐Eddin Al‐Batran,Ralf‐Dieter Hofheinz,et al.

2016720 citations

Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer

Salah‐Eddin Al‐Batran,Nils Homann,et al.

2017465 citations

Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial.

Salah‐Eddin Al‐Batran,Nils Homann,et al.

2017238 citations

Lymphocyte subsets' reference ranges in an age- and gender-balanced population of 100 healthy adults—A monocentric German study

Kathleen Jentsch‐Ullrich,Michael Koenigsmann,et al.

2005188 citations

Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse

Th. Büchner,Wolfgang Hiddemann,et al.

1991165 citations

Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell Transplantation

Nicolaus Kröger,Victoria Panagiota,et al.

2017105 citations

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

Mohamad Mohty,Evangelos Terpos,et al.

201889 citations

High-Dose Chemotherapy With Autologous Hematopoietic Stem-Cell Support Compared With Standard-Dose Chemotherapy in Breast Cancer Patients With 10 or More Positive Lymph Nodes: First Results of a Randomized Trial

A R Zander,Nicolaus Kröger,et al.

200481 citations